168. Ehlers-Danlos syndrome Disease details / Clinical trials / Drug dev / DR info

---

Clinical trials : 13 /  Drugs : 21 - (DrugBank : 11) / Drug target genes : 11 - Drug target pathways : 103

Other names	EDS;
Disease group	Chromosomal and gene abnormalities
Domestic patients Med expenses recipients (FY2023)	249 patients Age distribution💬 168. Ehlers-Danlos syndrome × Age Num 0-9 - 10-19 4 20-29 54 30-39 52 40-49 64 50-59 50 60-69 18 70-74 5 75- 2
Related info (in Japanese)	Biobank Animal model
Clinical research form [April 1, 2025 ~] (in Japanese)	Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) 168-01, 168-02, 168-03, 168-04, 168-05, 168-06, 168-07, 168-08, 168-09, 168-10, 168-11, 168-12, 168-13
Specific pediatric chronic diseases, Japan (in Japanese)	8-13-135. Ehlers-Danlos syndrome
Subtypes	No.	Name	Specific pediatric chronic diseases, Japan (in Japanese)
	168-1.	Classic EDS;Classical EDS;cEDS;
	168-2.	Hypermobile Ehlers-Danlos syndrome;Hypermobile EDS;hEDS;Classical-like Ehlers-Danlos syndrome;Classical-like EDS;clEDS;
	168-3.	Vascular Ehlers-Danlos syndrome;Vascular EDS;vEDS;
	168-4.	Kyphoscoliosis Ehlers-Danlos syndrome;Kyphoscoliosis EDS;kEDS;
	168-5.	Arthrochalasia Ehlers-Danlos syndrome;Arthrochalasia EDS;aEDS;
	168-6.	Dermatosparaxis Ehlers-Danlos syndrome;Dermatosparaxis EDS;dEDS;
	168-7.	D4ST1-deficient Ehlers-Danlos syndrome;Dermatan 4-0-sulfotransferase 1-deficient EDS;D4ST1-deficient EDS;DDEDS;